Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01891422 · ClinicalTrials.gov registry record
Longitudinal Studies of the Glycoproteinoses
A clinical trial, sponsored by Greenwood Genetic Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT01891422: Completed study, sponsored by Greenwood Genetic Center.
NCT01891422 is a clinical trial that has completed, run by Greenwood Genetic Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01891422 has completed, sponsored by Greenwood Genetic Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The glycoproteinoses are among the most rare and least researched of the lysosomal diseases. The diseases include aspartylglucosaminuria, fucosidosis, galactosialidosis, alpha-mannosidosis, beta-mannosidosis, mucolipidosis II, mucolipidosis III, Schindler disease, and sialidosis. Longitudinal studies of these conditions are needed in order to better define how common the diseases are, identify clinical features which could contribute to early diagnoses, detail progression of the diseases, assess the supportive therapies currently used, and identify potential treatments. Laboratory tests will evaluate metabolic and genetic defects found in participants' blood and urine samples.
Primary Outcome
Specific characteristics will be assessed by history and medical record review, to include: onset of disease presentation (signs and symptoms); age at presentation; timeframe of developmental milestones; milestones for educational achievement and cognitive measures; surgical procedures- when performed and outcomes; growth data over time; and indications for subspecialist care (for example cardiology, orthopedics, neurology).
Interventions
- OTHER Non-interventional.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-08 |
| Est. Completion | 2020-07 |
What the finished NCT01891422 record still lists
NCT01891422 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Non-interventional. is the first listed.
NCT01891422 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01891422 about?
NCT01891422 is a clinical study titled "Longitudinal Studies of the Glycoproteinoses". The glycoproteinoses are among the most rare and least researched of the lysosomal diseases. The diseases include aspartylglucosaminuria, fucosidosis, galactosialidosis, alpha-mannosidosis, beta-mannosidosis, mucolipidosis II, mucolipidosis III, Schindler disease, and sialidosis. Longitudinal studie...
What is the current status of trial NCT01891422?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-08. Estimated completion is 2020-07.
What interventions are being tested in trial NCT01891422?
The interventions under investigation include: Non-interventional. (OTHER).
Who is sponsoring clinical trial NCT01891422?
This trial is sponsored by Greenwood Genetic Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia